share_log

TherapeuticsMD Q2 EPS $(0.24) Misses $(0.07) Estimate, Sales From Cont Ops $400.00K Miss $500.00K Estimate

Benzinga ·  Aug 14, 2023 06:58

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.07) by 242.86 percent. This is a 93.02 percent increase over losses of $(3.44) per share from the same period last year. The company reported quarterly sales of $400.00 thousand which missed the analyst consensus estimate of $500.00 thousand by 20.00 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment